Characteristics, treatment patterns, healthcare resource use, and costs among adult patients diagnosed with neurofibromatosis type 1 and plexiform neurofibromas in the United States

Xiaoqin Yang, Mavis Obeng-Kusi, Theresa Dettling, Ayo Adeyemi, Marianne Cunnington, Qing Liu, Dominique Lejeune, Grace Chen, Mei Sheng Duh, Justin T Jordan · 2026

Read Characteristics, treatment patterns, healthcare resource use, and costs among adult patients diagnosed with neurofibromatosis type 1 and plexiform neurofibromas in the United States by Xiaoqin Yang, Mavis Obeng-Kusi, Theresa Dettling, Ayo Adeyemi, Marianne Cunnington, Qing Liu, Dominique Lejeune, Grace Chen, Mei Sheng Duh, Justin T Jordan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13292531.txt.

Description

Xiaoqin Yang and a large team measure a 2026 real-world burden in the United States: adults living with neurofibromatosis type 1 and plexiform neurofibromas, benign nerve tumors of that genetic disorder. Claims data from 2016 to 2022 supplied 944 patients, matched five-to-one with 4,720 controls. The team charted treatments, healthcare use, and costs with follow-up averaging 25.8 months.

Pain prescriptions were the commonest therapy at 69.5 percent of patients, ahead of debulking surgery at 22.9 percent and targeted MEK inhibitors at just 4.7 percent in the data. Patients used far more care than controls: 18.8 outpatient visits per year against 9.1, and six times the inpatient days. Over half of their hospital days traced directly to the NF1 or tumor diagnosis. The authors call the burden heavy and historically undertreated.

Catalog record

CREATORXiaoqin Yang, Mavis Obeng-Kusi, Theresa Dettling, Ayo Adeyemi, Marianne Cunnington, Qing Liu, Dominique Lejeune, Grace Chen, Mei Sheng Duh, Justin T Jordan
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60665
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13292531

Browse the full library · About the Tower of Babel